» Articles » PMID: 36866178

High-mobility Group Box 1 Protein, Receptor for Advanced Glycation End Products and Nucleosomes Increases After Marathon

Overview
Journal Front Physiol
Date 2023 Mar 3
PMID 36866178
Authors
Affiliations
Soon will be listed here.
Abstract

Prolonged and strenuous exercise has been linked to potential exercise-induced myocardial damages. One potential key to unmask the discussed underlying mechanisms of this subclinical cardiac damage could be markers of immunogenic cell damage (ICD). We investigated the kinetics of high-mobility group box 1 protein (HMGB1), soluble receptor for advanced glycation end products (sRAGE), nucleosomes, high sensitive troponin T (hs-TnT) and high sensitive C-reactive protein (hs-CRP) before and up to 12 weeks post-race and described associations with routine laboratory markers and physiological covariates. In our prospective longitudinal study, 51 adults (82% males; 43 ± 9 years) were included. All participants underwent a cardiopulmonary evaluation 10-12 weeks pre-race. HMGB1, sRAGE, nucleosomes, hs-TnT and, hs-CRP were analysed 10-12 weeks prior, 1-2 weeks before, immediately, 24 h, 72 h, and 12 weeks post-race. HMGB1, sRAGE, nucleosomes and hs-TnT increased significantly from pre- to immediately post-race (0.82-2.79 ng/mL; 1132-1388 pg/mL; 9.24-56.65 ng/mL; 6-27 ng/L; < 0.001) and returned to baseline within 24-72 h. Hs-CRP increased significantly 24 h post-race (0.88-11.5 mg/L; < 0.001). Change in sRAGE was positively associated with change in hs-TnT (rs = 0.352, = 0.011). Longer marathon finishing time was significantly associated with decreased levels of sRAGE [-9.2 pg/mL ( = -9.2, SE = 2.2, < 0.001)]. Prolonged and strenuous exercise increases markers of ICD immediately post-race, followed by a decrease within 72 h. An acute marathon event results in transient alterations of ICD, we assume that this is not solely driven by myocyte damages.

Citing Articles

Circulating Nucleosomes as a Novel Biomarker for Sepsis: A Scoping Review.

Su F, Moreau A, Savi M, Salvagno M, Annoni F, Zhao L Biomedicines. 2024; 12(7).

PMID: 39061959 PMC: 11273886. DOI: 10.3390/biomedicines12071385.

References
1.
Wittwer C, Lehner J, Fersching D, Siegele B, Stoetzer O, Holdenrieder S . Methodological and preanalytical evaluation of a RAGE immunoassay. Anticancer Res. 2012; 32(5):2075-8. View

2.
Mobius-Winkler S, Uhlemann M, Adams V, Sandri M, Erbs S, Lenk K . Coronary Collateral Growth Induced by Physical Exercise: Results of the Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial. Circulation. 2016; 133(15):1438-48. DOI: 10.1161/CIRCULATIONAHA.115.016442. View

3.
Volz H, Seidel C, Laohachewin D, Kaya Z, Muller O, Pleger S . HMGB1: the missing link between diabetes mellitus and heart failure. Basic Res Cardiol. 2010; 105(6):805-20. DOI: 10.1007/s00395-010-0114-3. View

4.
Malek L, Barczuk-Falecka M, Werys K, Czajkowska A, Mroz A, Witek K . Cardiovascular magnetic resonance with parametric mapping in long-term ultra-marathon runners. Eur J Radiol. 2019; 117:89-94. DOI: 10.1016/j.ejrad.2019.06.001. View

5.
Bell C, Jiang W, Reich 3rd C, Pisetsky D . The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006; 291(6):C1318-25. DOI: 10.1152/ajpcell.00616.2005. View